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Medicinal plants indicated for chronic diseases usually have good safety margins as they
are intended for lifelong treatments. We hypothesized that they may provide patients with
baseline protection to cancers and multidrug resistance-reversing phytochemicals
resulting in successful prevention and/or adjuvant treatment of chemotherapy-resistant
cancers. We selected 27 popular herbal infusions widely used in Nigeria for diabetes and
studied their effects on a panel of liver (HepG2), colon (Caco2), and skin (B16-F10) cancer
cells. Cytotoxicity was measured using the SRB staining assay. The 2D antimigratory
effect was evaluated using an Oris™ platform. The P-glycoprotein (P-gp) efflux activity
was evaluated using Rh-123 as a fluorescent probe. The inhibition of tyrosinase-mediated
melanogenesis was evaluated by colorimetric enzymatic assays. Our results show that
melanoma cell proliferation was strongly inhibited by Anogeissus leiocarpus
(Combretaceae), Bridelia ferruginea (Phyllanthaceae), D. ogea (Leguminosae), and
Syzygium guineense (Myrtaceae) extracts (GI50 = 50 µg/ml). Alstonia boonei
(Apocynaceae), Gongronema latifolium (Asclepiadaceae), and Strophanthus hispidus
(Apocynaceae) were preferentially toxic against Caco2 (GI50 = 50, 5 and 35 µg/ml,
respectively). The most active extracts against different drug resistance mechanisms
were B. ferruginea (inhibition of P-gp efflux, and impairing tyrosinase activity) and X.
americana (inhibition of P-gp efflux). A. leiocarpus, Kaya senegalensis (Meliaceae), S.
guineense, and Terminalia avicennioides (Combretaceae) significantly inhibited B16-F10
cell migration. Lupeol, ursolic acid, quercitrin, epicatechin, gallic acid, and ellagic acid
were dereplicated by HPLC and HPTLC as their bioactive phytochemicals. In conclusion,
the above in-vitro activities of herbal infusions regularly consumed by Nigerian diabetic
patients may either act as a baseline chemoprotection or as sensitizing agents.
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Natural products are both the base of traditional medicine and
important sources of lead molecules in drug discovery (Thomford
et al., 2018). One of the main global challenges to current cancer
treatment is the emergence of multidrug resistance (MDR) to
chemotherapeutic drugs, defined as acquired resistance to
structurally and/or functionally unrelated drugs (Viale and
Draetta, 2016). It is known that many herbal extracts
(traditional medicines) act as chemosensitizers or resistance
modulators (Tinoush et al., 2020). A key aspect of their activity
is their ability to modulate multiple survival pathways with very
low toxicity (Aung et al., 2017). Despite intense research, the
choice of synthetic drugs against MDR is very limited (Dallavalle
et al., 2020). The search for new natural product addressing this
gap offers potential new avenues. Hence, our research groups is
actively screening and testing for candidates from natural sources
that can modulate the function, or expression, of disease-linked
ABC transporters (Syed and Coumar, 2016).
The selected 27 plants in this work are widely used for
diabetes and metabolic disorders in Nigeria, the most
populated African country. Most of them are easily found in
herbal markets all over the country for other primary indications
including both common infective and non-communicable
diseases Some of them have anecdotical records of use for the
treatment of cancer without in-depth studies (Ezuruike and
Prieto, 2014). These traditional medicines are consumed for
years with apparently little toxicity and therefore may provide
with a baseline defense against cancer, by killing or preventing
tumor cells to acquire new hallmarks (Pan and Ho, 2008; Hodek
et al., 2009). The real impact of cancer in Nigeria was largely
unknown due to either a lack of statistics or under-reporting
until the creation of the Nigerian National System of Cancer
Registries in 2009 (The African Cancer Registry Network; Jedy-
Agba et al., 2012). Emerging figures point out that more than
100,000 patients diagnosed with cancer and 70,000 deaths occur
every year. These figures mean that about 1 in 10 Nigerians
develop cancer before age 75 (International Agency for Research
on Cancer).
In line with the topic of this special issue, we studied the
cytotoxicity of the aqueous plant extracts (infusions) toward a
panel of liver (HepG2), colon (Caco2) and skin (B16-F10) cancer
cells as well as their effects upon selected mechanisms of drug
resistance in cancer cells, namely, the efflux of xenobiotics by P-
gp (Ozben, 2006), and the ability to inhibit tyrosinase-mediated
melanogenesis and melanoma migration capacity (Pinon et al.,
2011). Finally, we have proceeded to the identification of
potential bioactive metabolites contributing to the effects of
these plant extracts.MATERIALS AND METHODS
Plant Material
Plant materials were either bought in markets or collected from
different regions in Nigeria in November 2012 by one of theFrontiers in Pharmacology | www.frontiersin.org 2authors (U.F. Ezuruike). Table 1 summarizes their botanical
details and precedence. Identification of collected plant samples
collected in the north was done by Mr. Ibrahim Muazzam, an
ethnobotanist and staff of the Department of Medicinal Plant
Research & Traditional Medicine, National Institute for
Pharmaceutical Research & Development (NIPRD). Plant
samples collected in the south were verified by staff of the
Forestry Research Institute of Nigeria (FRIN) in Ibadan.
Vouchers were deposited in the Department of Pharmaceutical
and Biological Chemistry, University College London School of
Pharmacy, United Kingdom. Voucher numbers are provided in
Supplementary materials.
Plant Sample Preparation and Extraction
All plant samples were air-dried for about two weeks (average
temperature 30°C) to remove as much moisture as possible to
prevent deterioration. Samples were then packed in freezer bags
and shipped to the School of Pharmacy, University College
London. Upon arrival, they were further dried in a Samas
Vickers® laboratory drying chamber electrically heated to 30°C
with continuous ventilation. Samples were powdered using a
laboratory scale mill (MF 10 Basic IKA WERKE blender) or an
industrial size mill (Fritsch, Germany), depending on the part of
the plant collected and the quantity of plant material.
The procedure for extraction of the plant samples (infusion or
decoction) was based on the traditional use of the plants as
described by the respondents (Table 1). For infusion, 300 ml of
boiled distilled water was added to 10 g of plant material with
continuous stirring for 15 min on a laboratory hot plate magnetic
stirrer (IKAWERKE labortechnik electric stirrer). For decoction,
20 g of plant material was heated continuously under reflux in a
round bottom flask containing 400 ml of distilled water for 1 h
using an Electrothermal® 3-in-1 laboratory heating mantle. All
extracted plant samples were then allowed to stand until cold
before filtering with a Buchner flask. All the filtered extracts were
frozen in round bottom flasks and then freeze dried (Edwards
Pirani 50 L Savant super modulo freeze drier) to obtain the dried
extract. All dried plant extracts were then stored in 10 ml sample
bottles at −20°C until needed.
For analyses and cell assays, plant stock concentrations (50
mg/ml) were prepared by dissolving crude extracts in bidistilled,
microfiltered, aseptic water (MiliQ). The solutions were cold
sterilized by microfiltration (Millipore disk filters, 0.22 microns)
in a laminar flow cabinet into sterile microcentrifuge tubes.
These aliquots were at −80°C until further testing.
HPTLC Analyses
Plant extracts and phytochemical standards were diluted in
methanol to a concentration of 50 and 1 mg/ml, respectively.
A Linomat 5 (CAMAG, Switzerland) was used to apply 5 ml of
the samples to HPTLC silica gel (Merck, Germany). The plates
were developed using a CAMAG ADC2 automatic developing
chamber. The method included 30-s pre-drying, 10 min
humidity control using magnesium chloride to 48.3% relative
humidity and 20 min saturation time, using saturation pads all
done at 25.2°C. The mobile phase used was Chloroform-
Methanol (8:2). During development, the solvent front wasSeptember 2020 | Volume 11 | Article 546439
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derivatization, we used Anisaldehyde/H2SO4. All visualization
and analysis were done using CAMAG TLC visualizer both
before and after derivatization. Phytochemical standards and
solvents were from Sigma-Aldrich (UK).
HPLC-DAD Analyses
Active plant samples were fingerprinted by HPLC-UV.
Chromatograms were obtained in an Agilent 1100 Series
(Gradient Quaternary Pump, Online degasser, Photodiode array
detector) Software ChemStation. Elution conditions for
phytomarkers were as previously described (Giner et al., 1993) on
a Phenomenex® C18 column (250 × 4.6 mm id, 5 mm). Solvent A
(H2O + Acetic Acid 0.2%) and B (methanol + Acetic Acid 0.2%
were mixed in gradient mode as follows: 0 min 90% A, 0 to 5 min
80% A, 5 to 45 min 50% A, 45 to 55 min 20% A; flow rate 0.8 ml/
min. The injection volume, column temperature, and UV
wavelength were set at 80 ml, 30°C and 254 nm, respectively.
Phytochemical standards and solvents were from Sigma-
Aldrich (UK).
Cell Lines and Cell Culture
Caco-2 wild type cells (Sigma-Aldrich) were cultured in DMEM
medium (GIBCO) supplemented with 10% FBS, penicillin (100 U/
ml), streptomycin (100 mg/ml), and 1% non-essential amino acid
(NEEA). The HepG2 and Caco2 cells were purchased from Sigma
(UK). B16-F10 murine melanoma cell lines were from Professor
Kostas Kostarelos (Centre for Drug Delivery Research, School of
Pharmacy, UCL, UK). HepG2 cells (Sigma-Aldrich) were cultured in
MEM medium (GIBCO) supplemented with 10% FBS, penicillinFrontiers in Pharmacology | www.frontiersin.org 3(100 U/ml), streptomycin (100 mg/ml). B16-F10 cells were cultured
in DMEM medium (GIBCO) supplemented with 10% FBS,
penicillin (100 U/ml), streptomycin (100 mg/ml). B16-F10 Cells
were grown at 37°C and maintained in DMEM Glutamex
(Dulbecco’s Modified Eagle Media) containing 4,500 mg/L D-
glucose, L-glutamine (3.97 mM) and sodium pyruvate. The media
was supplemented with 10% of heat-inactivated fetal bovine serum
(FBS) (Gibco) and 1% penicillin-streptomycin antibiotic which
consists of 10,000 units of penicillin and 10,000 µl of streptomycin
per ml to inhibit bacterial growth. All cells were kept at 37°C in an
incubator with a humidified atmosphere of 5% CO2.
Antiproliferation Assays
The NCI protocol for SRB staining was followed as previously
described (Skehan et al., 1990; National Cancer Institute, 2020).
Briefly, HepG2, Caco-2, and B16-F10 cells were cultured in 96-
well tissue culture plates by adding 200 ml/well of a suspension of
2 × 104, 1 × 104, and 2 × 104 cells/well respectively. After cells
reached 80% confluence the culture medium was replaced with
fresh medium containing 100 mg/ml of plant extracts. After 24-h
incubation with the plant extracts, media containing the samples
was removed, and cells were fixed with 100 µl of cold 40% w/v
trichloroacetic acid (TCA) solution in deionized water. The plates
were incubated at 4°C for 1 h and then rinsed five times with slow
running-tap water. The TCA-fixed cells were stained by adding
100 µl of SRB solution (0.4% SRB in 0.1% acetic acid) and left at
room temperature for 1 h. Afterward, the plates were quickly
rinsed four times with 1% acetic acid and flicked to remove
unbound dye and then left to air-dry overnight. After drying
completely, the protein bound SRB was solubilized by adding 100TABLE 1 | Summary of the botanical origin and extraction methods of the plant extracts.
Sample ID Plant name Family Plant Part Place of collection/purchase Extraction method Yield (%w/w)
AB Alstonia boonei De Wild. Apocynaceae Stembark Herbal market, Mushin Decoction 5.03
AS Annona senegalensis Pers. Annonaceae Stembark Forest, Agbede Decoction 7.10
AL Anogeissus leiocarpa (DC.) Guill. & Perr. Combretaceae Stembark Herbal shop, Abuja Decoction 6.21
AD Anthocliesta djalonensis A.Chev. Gentianaceae Stembark Forest, Agbede Decoction 3.05
AR Aristolochia repens Mill. Aristolochiaceae Stem Herbal market, Mushin Infusion 18.11
BF Bridelia ferruginea Benth. Phyllanthaceae Stembark Herbal market, Ibadan Decoction 75.86
CS Cassia sieberiana DC. Leguminosae Root Forest, Agbede Decoction 10.27
CF Cassytha filiformis L. Lauraceae Whole plant NIPRD, Abuja Decoction 12.66
DO Daniellia ogea (Harms) Holland Leguminosae Stembark Forest, Agbede Decoction 6.05
GL Gongronema latifolium Benth. Apocynaceae Leaves Herbal market, Mushin Infusion 8.37
ID Isoberlinia doka Craib & Stapf Leguminosae Stem Herbal market, Zaria Decoction 4.69
KI Khaya ivorensis A.Chev. Meliaceae Stembark Herbal market, Mushin Decoction 7.83
KS Khaya senegalensis (Desv.) A.Juss. Meliaceae Stembark Forest, Agbede Decoction 5.02
MO Moringa oleifera Lam. Moringaceae Leaves Home garden, Imo Infusion 35.54
MW Mondia whitei (Hook.f.) Skeels Apocynaceae Stem Herbal market, Mushin Infusion 20.24
OG Ocimum gratissimum L. Lamiaceae Leaves Herbal market, Mushin Infusion 17.04
PN Picralima nitida (Stapf) T.Durand & H.Durand Apocynaceae Seeds Herbal market, Ibadan Infusion 23.71
RV Rauvolfia vomitoria Afzel. Apocynaceae Stembark Herbal market, Ibadan Decoction 3.9
SD Scoparia dulcis L. Plantaginaceae Whole plant NIPRD, Abuja Decoction 16.35
SL Securidaca longipedunculata Fresen. Polygalaceae Root Herbal market, Mushin Decoction 7.49
SH Strophanthus hispidus DC. Apocynaceae Stem Herbal market, Ibadan Decoction 12.2
SG Syzygium guineense (Willd.) DC. Myrtaceae Stem Herbal market, Zaria Decoction 8.01
TA Terminalia avicennioides Guill. & Perr. Combretaceae Stem Herbal market, Zaria Decoction 13.25
TB Tapinanthus bangwensis (Engl. & K.Krause) Loranthaceae Leaves Herbal shop, Imo Infusion 32.2
TI Tamarindus indica L. Leguminosae Stem Herbal market, Zaria Decoction 6.05
VA Vernonia amygdalina Delile Compositae Leaves Home garden, Lagos Infusion 15.54
XA Ximenia americana L. Olacaceae Stem Herbal market, Zaria Decoction 11.5September 2020 | Volume 11 | Article 546439
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agitated in an orbital shaker for 30 min. The optical density was
measured at 492 nm by using a microtiter plate reader (Tecan,
Switzerland). Both Growth Inhibition 50% (GI50) and Maximum
Non-Toxic Concentrations (MNTC) were calculated for each
cell line.
Rhodamine 123 Uptake Assay
Rhodamine uptake/efflux assays were conducted as previously
described (Chieli et al., 2009) with minor modifications. Cells
were seeded into 96-well plates for 24 h to allow for attachment.
Then, the growth media was changed to serum free media.
Rhodamine (5 µg/ml) was added to the wells containing 100
µg/ml of all the extracts to be tested. 20 µM verapamil was used
as positive control. After 2 h incubation, cells were washed with
20 µM verapamil in PBS. Cells were lysed with 100 µl of 0.1%
Triton X-100 in PBS and the plates were placed in the incubator
for 15 min. 80 µl of each of the cell lysates in each well was
transferred to a 96-well black plate and the fluorescence intensity
of each well was measured in a Tecan® plate reader (Exc-485 nm,
Em-525 nm). The cellular accumulation of Rh-123 for each of
the extracts was expressed as the percentage of the accumulation
measured for rhodamine only, that is under control conditions.
Tyrosinase Activity Assay
Tyrosinase inhibitory activity was assessed as previously
described (Masuda et al., 2007). Briefly, L-tyrosine 2.5 mM -in
PBS- and the sample- in DMSO- are mixed in a total volume of
160 µl to which 40 µl of Mushroom tyrosinase (46 units/ml) is
added. After 20 min, the absorbance was measured for each well
at 475 nm, then the % of Tyrosinase inhibition calculated against
the control and corrected with matched blanks. All reagents were
from Sigma-Aldrich (UK).
2D Migration Assay
The cell migration was measured using OrisTM Universal Cell
Migration Assembly Kit. In this assay, inserts were used to create
an exclusion zone in a cell monolayer. For the migration assay, the
sterile stoppers were introduced in a flat-bottom 96-well plate before
starting cell seeding. B16-F10 cells were plated at a density of 7.5 ×
104 cells per well. After 24 h of incubation, a monolayer had been
formed with an exclusion zone in the center. Afterward, the
stoppers were removed manually and then the cells were
incubated with the MNTC of each extract, vehicle control and
hydroxyurea at (75 µM), which used as a positive control in this
assay. At the end of the incubation period, the cells were fixed with
100 µl of cold 40% TCA. The plates were kept at 4°C for 1 h and
rinsed with water. The cells were stained by the addition of 50 µl of
trypan blue and incubated at room temperature for 1 h. Another
washing step was performed, and the plate was then left to air-dry
completely overnight. Measurement of zone closure was performed
by digital images obtained by optical scanning (transmittance
mode) by a Snapscan e50 (Agfa-Gevaert, Germany). Image J
(National Health Institute, USA) was used to measure an average
gap distance value and compare to the vehicle control in order to
monitor the migratory capacity of the treated cells. The migration
rate was calculated as follows: %Migration rate = [gap distance (dayFrontiers in Pharmacology | www.frontiersin.org 40) − gap distance of the extract (24 h)]/[gap distance (day 0) − gap
distance of vehicle control (24 h)].
Statistics
Curve fittings, GI50s and IC50s were performed with Excel
®
(Microsoft, Redmon) and GraphPad® Instat version 3
(GraphPad Software, La Jolla, US). Significance of the results
was assessed with Instat® (GraphPad Software, La Jolla, US).RESULTS AND DISCUSSION
Cytotoxicity of the Extracts
Rather than calculating exact values, we classified the GI50 between
standard doses and applied the threshold proposed by Suffness and
Pezzuto (1999), which establishes that crude extracts showing an GI50
≤ 100 µg/ml can be considered to be cytotoxic and selected for further
studies, whereas the most promising ones are those with an GI50
lower than 30 µg/ml. None of the plants shown cytotoxicity toward
all the cells in the panel, thus providing certain degree of specificity.
The most promising cytotoxic activity was shown by G. latifolium
against Caco2 colorectal cancer cells (GI50 < 10 µg/ml). Three species
(D. ogea, S. hispidus, and A. senegalensis) were able to exert toxic
effects on two different cell lines. Rat melanoma B16-F10 cells
proliferation was strongly inhibited by A. leiocarpus, B. ferruginea,
and S. guineense extracts, while A. boonei G. latifolium, S. dulcis, and
S. hispidus were preferentially toxic against the human colon
carcinoma Caco2 cell line. Finally, extracts from K. ivorensis and S.
hispidus affected HepG2 human liver carcinoma cells only (Table 2).
Effect on Putative Drug
Resistance Mechanisms
The MDR-1 gene and its product, P-glycoprotein, are considered
to be among the most important drug-resistance mechanisms in
cancer cells (Ozben, 2006). Nine extracts obtained from A.
senegalensis, B. ferruginea, C. filiformis, D. ogea, K. ivorensis, S.
guineense, T. avicennioides, and X. americana produced a change
in intracellular accumulation of Rh-123 which was significantly
different from the control cells in Caco-2 cells (Figure 1) whichSeptember 2020 | Volume 11 | Article 546439TABLE 2 | Effects of active plant extracts on cancer cell using the SRB assay.
Plant extract Proliferation (GI50 µg/ml)
HepG2 CACO2 B16-F10
A. boonei – ≈50 –
A. leiocarpus – – ≈ 50
A. senegalensis. – ≈75 ≈ 100
B. ferruginea – – ≈ 50
C. filiformis – – –
D. ogea ≈50 – ≈ 50
G. latifolium. – ≈5 –
K. ivorensis ≈100 – –
K. senegalensis – – –
S. guineense – – ≈50
S. hispidus ≈75 ≈35 –
T. avicennioides – – ≈ 100
T. bangwensis – – ≈100
Paclitaxel ≈0.03 ≈0.01 ≈0.09
AlQathama et al. Nigerian Plants and Multidrug Resistancesuggests that they are acting as P-gp inhibitors.
In Caco-2 cells, the highest observed inhibitory effect was
produced by B. ferruginea with more than 500% increase in Rh-
123 accumulation compared to control cells followed by XA1 with
more than 400% increase. The inhibitory effects of B. ferruginea
and X. americana were thrice and twice higher than the effect of
the positive control verapamil, respectively. Such high changes in
intracellular Rh-123 accumulation by plant extracts are not
uncommon. A similar study carried out with the stem bark
extract of Mangifera indica produced a 1,000% increase in
intracellular Rh-123 accumulation (Chieli et al., 2009).
Another emerging multidrug resistance mechanism in
melanoma is melanin synthesis. Chen et al. demonstrated that
melanosomes contribute to the refractory properties of melanoma
cells by sequestering cytotoxic drugs and increasing melanosome-
mediated drug export. Thus, preventing melanosomal sequestration
of cytotoxic drugs by inhibiting the functions of melanosomes
may have great potential as an approach to improving the
chemosensitivity of melanoma cells (Chen et al., 2006).
Furthermore, the same authors later established that the intrinsic
MDR of melanoma cells is related to the ABC transporter systems
-which includes P-gp- that may also play a critical role in reducing
toxic melanin intermediates and metabolites (Chieli et al., 2009).
The extracts that inhibited DOPA production under 100 µg/ml
were A. senegalensis (22% ± 12), B. ferruginea (48% ± 10), D. ogea
(32%± 14) and S. guineense (11%± 1) with Kojic acid showing an
IC50 of 12.65 ± 3 µM in our conditions.
Antimigratory Activity
Figure 2 shows the effect of the active extracts on the cellular
migration of the B16-F10. In vitro antimigratory activity against
the highly metastatic B16-F10 cell line at 200 µg/ml was shown by A.
boonei, A. leiocarpus, K. senegalensis, and T. avicennioides, while pro-
migratory activity was detected for C. filiformis. The decoction of S.
guineense was the most active at inhibiting migration but the cell
population shown signs of toxicity. Of note, D. ogea, A. senegalensis,Frontiers in Pharmacology | www.frontiersin.org 5B. ferruginea, M. whiteii, and T. bangwensis did not exhibit a
significant inhibitory effect of the 2D cell migration assay even
when assayed at cytotoxic concentrations. When tested at MNTC
onlyA. boonei,K. senegalensis, and T. avicennioides kept their activity.
A sequential liquid/liquid extraction of the extracts was
performed to obtain chloroform (C), butanol (B) and water
(W) fractions with significant antimigratory effects at 100 µg/ml
as shown in Figure 3: AB-C, AL-B, KS-B, KS-W, SG-B, SG-W,
and TA-W. When tested at MNTC only AB-C, KS-B, and KS-W
kept their activity intact.
Dereplication of Known
Bioactive Compounds
Screening of natural products for potential anticancer activities must
always be accompanied by dereplication strategies so to avoid
needless isolation of known bioactive compounds (Corley and
Durley, 1994).
All extracts were chromatographed and dereplicated for Gallic
acid, caffeic acid, epicatechin, epigallocatechin, catechin, vitexin
rhamnoside, vitexin, rutin, ellagic acid, quercitrin, hesperidin,
quercetin, luteolin, kaempferol, ursolic acid, betulinic acid, and
lupeol. The resulting chromatograms are provided as
supplementary materials. Supplementary Table 1 summarizes
the phenolic compounds detected in our plant samples versus
those already reported in literature for the plant species.
The activities of A. boonei may be explained by the presence
of lupeol [1], ursolic acid [2] (TLC) and quercitrin [6] (HPLC);
A. leiocarpus contains Epicatechin [5], Gallic acid [3], and ellagic
acid [4] (HPLC) and S. guineense Gallic acid [3] (HPLC). Their
chemical structures are presented in Figure 4.
Lupeol [1] and ursolic acid [2] are regarded as powerful
inducers of apoptosis in cancer cells with added modulatory
effects upon drug resistance mechanisms in cancer cells
including P-gp activity (Yan et al., 2014). Gallic acid [3]
besides its well- known antioxidant activity can decrease P-gp
expression in HK-2 cells (Chieli et al., 2010) and directly modifyFIGURE 1 | Intracellular Rh-123 concentration in Caco-2 cells after treatment with either extract (final concentration 100 µg/ml) or reference drug (Verapamil, VP).
One-way ANOVA followed by Bonferroni’s post-test; Data are presented as the mean ± SD (n = 3), (****) p <0.0001 (***) p < 0.001; (*) p < 0.05, respectively.September 2020 | Volume 11 | Article 546439
AlQathama et al. Nigerian Plants and Multidrug Resistanceits function on KB-C2 cells (Kitagawa et al., 2004). Ellagic acid
[4], Epicatechin [5], and quercitrin [6] are also endowed with
anticarcinogenic effects by inhibiting tumor cell proliferation,
inducing apoptosis and inhibiting drug-resistance processes—
specially efflux pumps and transporters—required for tumor
growth (Tan et al., 2013; Zhang et al., 2014). Moreover, all
these chemicals are inhibitors of migration of melanoma cell
lines (Alqathama and Prieto, 2015).Frontiers in Pharmacology | www.frontiersin.org 6CONCLUSIONS
This study results demonstrated that some of these herbal
medicines are endowed with significant in vitro cytotoxicity
and inhibit MDR mechanisms. More refined studies would be
necessary to ascertain the in vivo and/or clinical significance of
such properties. In terms of direct cytotoxic effects, the aqueous
extracts of G. latifolium and S. hispidus emerge as promisingFIGURE 3 | 2D anti-migratory effects of fractions of active plant extracts with inhibitory effect at both GI50 and MNTC on B16-F10 murine melanoma cells after 24 h.
Area of the gap (measured in pixels) in a confluent cell monolayer immediately after gap generation (0 h) and at 24 h post-wounding. HU: Hydroxyurea (reference
compound, 75 µM); C: chloroform fraction; B: butanol fraction; W: water fraction. Data are presented as the mean ± SD (n = 3), (***) p < 0.001; (**) p < 0.01;
(*) p < 0.05, respectively.FIGURE 2 | 2D anti-migratory effects of the selected extracts at both GI50, MNTC and reference compound (HU 75 µM) on B16-F10 murine melanoma cells for
24 h. Area of the gap (measured in pixels) in a confluent cell monolayer immediately after gap generation (0 h) and at 24 h post-wounding (n = 3) with representative
microscopy images for the treated gaps. The significance of inhibitory effect was determined by one-way ANOVA followed by Bonferroni’s post-test with respect to
t24 control; Data are presented as the mean ± SD (n = 3), (***) p < 0.001; (**) p < 0.01; (*) p < 0.05, respectively.September 2020 | Volume 11 | Article 546439
AlQathama et al. Nigerian Plants and Multidrug Resistanceleads according the strictest standards (GI50 < 30 µg/ml, Caco2
cells). It is conceivable that traditional infusions can reach
pharmacologically active levels in the gastrointestinal system.
Therefore, their chronic intake by diabetic patients may provide
a baseline protection against colon cancer. This warrants further
in vivo studies to confirm if their active principles are not
degraded in the stomach and can reach the colon.
On the other hand, B. ferruginea and X. americana shown the
largest effects on P-gp efflux, a clinically relevant target. These
herbs have additional inhibitory effects on other putative MDR
mechanisms namely depletion of glutathione as per our previous
work (Ezuruike et al., 2019) and impairing tyrosinase activity (as
per this work), respectively. Thus, they are clear candidates for
adjuvant or combination cancer therapy.
Our study also shows for first time that the following herbal
extracts exert in vitro antimigratory activity against the highly
metastatic B16-F10 cell line: A. leiocarpus, K. senegalensis, S.
guineense, and T. avicennioides. Some of their bioactive
phytochemicals (lupeol, ursolic acid gallic acid, ellagic acid,
epicatechin, and quercitrin) were dereplicated by HPLC
and HPTLC.
Although further studies are needed to attest the clinical
relevance of our findings, we hope that this work will stimulate
similar research toward establishing the clinical relevance of these
herbal medicines in Nigeria.DATA AVAILABILITY STATEMENT
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